Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial - PubMed (original) (raw)
Clinical Trial
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial
P Gentilini et al. J Hepatol. 1999 Apr.
Abstract
Background/aims: Diuretic treatment of ascites could result in intravascular volume depletion, electrolyte imbalance and renal impairment. We investigated whether intravascular volume expansion with albumin exert beneficial effects in cirrhosis with ascites.
Methods: In protocol 1, 126 cirrhotic inpatients in whom ascites was not relieved following bed rest and a low-sodium diet, were randomly assigned to receive diuretics (group A) or diuretics plus albumin, 12.5 g/day (group B). In protocol 2, group A patients continued to receive diuretics and group B diuretics plus albumin (25 g/week) as outpatients and were followed up for 3 years. End points were: disappearance of ascites, duration of hospital stay (protocol 1), recurrence of ascites, hospital readmission and survival (protocol 2).
Results: The cumulative rate of response to diuretic treatment of ascites was higher (p < 0.05) and hospital stay was shorter (20 +/- 1 versus 24 +/- 2 days, p < 0.05) in group B than in group A patients. After discharge, group B patients had a lower cumulative probability of developing ascites (19%, 56%, 69% versus 30%, 79% and 82% at 12, 24 and 36 months, p < 0.02) and a lower probability of readmission to the hospital (15%, 56%, 69% versus 27%, 74% and 79%, respectively, p < 0.02). Survival was similar in the two groups.
Conclusions: Albumin is effective in improving the rate of response and preventing recurrence of ascites in cirrhotic patients with ascites receiving diuretics. However, the cost/benefit ratio was favorable to albumin in protocol 1 but not in protocol 2.
Comment in
- Intravenous albumin with diuretics: protean lessons to be learnt?
Blendis L, Wong F. Blendis L, et al. J Hepatol. 1999 Apr;30(4):727-30. doi: 10.1016/s0168-8278(99)80207-4. J Hepatol. 1999. PMID: 10207818 No abstract available. - Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and refractory ascites.
Schindler C, Ramadori G. Schindler C, et al. J Hepatol. 1999 Dec;31(6):1132. doi: 10.1016/s0168-8278(99)80329-8. J Hepatol. 1999. PMID: 10604590 No abstract available.
Similar articles
- Intravenous albumin with diuretics: protean lessons to be learnt?
Blendis L, Wong F. Blendis L, et al. J Hepatol. 1999 Apr;30(4):727-30. doi: 10.1016/s0168-8278(99)80207-4. J Hepatol. 1999. PMID: 10207818 No abstract available. - Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.
Ginés P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, Viver J, Camps J, Jiménez W, et al. Ginés P, et al. Gastroenterology. 1987 Aug;93(2):234-41. doi: 10.1016/0016-5085(87)91007-9. Gastroenterology. 1987. PMID: 3297907 Clinical Trial. - Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
Arroyo V, Ginès P, Planas R. Arroyo V, et al. Gastroenterol Clin North Am. 1992 Mar;21(1):237-56. Gastroenterol Clin North Am. 1992. PMID: 1568775 Review. - Management of ascites in patients with cirrhosis. What to do when diuretics fail.
Porayko MK, Wiesner RH. Porayko MK, et al. Postgrad Med. 1992 Dec;92(8):155-8, 161-6. doi: 10.1080/00325481.1992.11701557. Postgrad Med. 1992. PMID: 1454665 Review.
Cited by
- Albumin: a comprehensive review and practical guideline for clinical use.
Abedi F, Zarei B, Elyasi S. Abedi F, et al. Eur J Clin Pharmacol. 2024 Aug;80(8):1151-1169. doi: 10.1007/s00228-024-03664-y. Epub 2024 Apr 12. Eur J Clin Pharmacol. 2024. PMID: 38607390 Review. - Role of albumin infusion in cirrhosis-associated complications.
Heybe MA, Mehta KJ. Heybe MA, et al. Clin Exp Med. 2024 Mar 29;24(1):58. doi: 10.1007/s10238-024-01315-1. Clin Exp Med. 2024. PMID: 38551716 Free PMC article. Review. - Outpatient albumin infusions reduce hospitalizations and improve outcomes in decompensated cirrhosis: A real-world cohort study.
Hannah N, Tjandra D, Patwardhan A, Rutland K, Halliday J, Sood S. Hannah N, et al. JGH Open. 2023 Jul 27;7(8):537-544. doi: 10.1002/jgh3.12944. eCollection 2023 Aug. JGH Open. 2023. PMID: 37649856 Free PMC article. - Use of albumin infusion for cirrhosis-related complications: An international position statement.
Bai Z, Méndez-Sánchez N, Romeiro FG, Mancuso A, Philips CA, Tacke F, Basaranoglu M, Primignani M, Ibrahim M, Wong YJ, Nery FG, Teschke R, Ferreira CN, Muñoz AE, Pinyopornpanish K, Thevenot T, Singh SP, Mohanty A, Satapathy SK, Ridola L, Maruyama H, Cholongitas E, Levi Sandri GB, Yang L, Shalimar, Yang Y, Villa E, Krag A, Wong F, Jalan R, O'Brien A, Bernardi M, Qi X; Liver Cirrhosis-related Complications (LCC)-International Special Interest Group. Bai Z, et al. JHEP Rep. 2023 May 5;5(8):100785. doi: 10.1016/j.jhepr.2023.100785. eCollection 2023 Aug. JHEP Rep. 2023. PMID: 37456673 Free PMC article. - Ascites and Chronic Liver Disease in Children.
Bolia R, Srivastava A. Bolia R, et al. Indian J Pediatr. 2024 Mar;91(3):270-279. doi: 10.1007/s12098-023-04596-8. Epub 2023 Jun 13. Indian J Pediatr. 2024. PMID: 37310583 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical